Recs

7

5 Dynamic Dividend Stocks

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

The New York Yankees of the '50s and the Chicago Bulls and Dallas Cowboys of the '90s had one crucial element in common: consistent excellence in their organizations and performance. That's a rare accomplishment, but if you think it could never occur in your portfolio, think again. Carefully chosen dividend-paying stocks could be your key to superstar returns.

Build the next investing dynasty
These long-haul outperformers can help you build your fortune, as studies from investing gurus such as Jeremy Siegel have shown time and time again. Finding them is our Motley Fool Income Investor service's mission.

Johnson & Johnson (NYSE: JNJ  ) , for example, has returned 20% since April 2006, and it currently is rewarding investors with a 3.1% yield. Or consider Enterprise Products Partners (NYSE: EPD  ) , which has climbed 98% since May 2004, atop a current 6.6% yield. While these stocks happen to be Income Investor recommendations, you don't need to be a subscriber to get these great gains.

Identify new talent
With the help of Motley Fool CAPS, we'll search for the best dividend-paying stocks around. Here are several dividend picks that have also earned high ratings from the 150,000 members of our CAPS community:

Company

Yield

CAPS Rating (out of 5)

Marathon Oil (NYSE: MRO  )

3.2%

*****

Allstate (NYSE: ALL  )

2.7%

****

Verizon (NYSE: VZ  )

6.5%

****

Caterpillar (NYSE: CAT  )

3.2%

****

Pfizer (NYSE: PFE  )

3.9%

****

Source: Capital IQ a division of Standard & Poor's and CAPS.

Any one of these quality companies would add some dividend pizzazz to your portfolio, but let's take a closer look at how Allstate stacks up.

Does my dividend have a glass jaw?
The last thing we want in a dividend paying company is the risk that the company will fall off a cliff and have to pull back its dividend. This usually ends up being a double whammy because not only do you lose your dividend payout, but many of the dividend-loving investors that own the stock will run for the hills, causing the stock price to fall.

With that in mind, there are three places that I immediately tune into when kicking the tires of a dividend payer -- dividend history, financial statements, and business stability.

From the debt perspective, Allstate's balance sheet is pretty sound, with a total debt-to-equity ratio of 35%. It's been the asset side of the company's balance sheet that's been causing indigestion in recent times though. In 2008, the company reported a hefty $1.7 billion loss, thanks in large part to hits it took on its investment portfolio.

But it wasn't just the bottom line that suffered from those investment losses. As a result of the losses, Allstate also decided to slash its dividend last year -- more than halving the payout. That move ended a 14-year streak of annually raising its dividend.

In all, the picture may seem pretty bleak for dividend investors. In fact, for many hardcore income-seekers, a payout cut like that is reason enough to write off the stock. However, there may still be reason to take a chance on Allstate.

The company's fourth-quarter results showed its investment portfolio continuing to improve, while its core business plugged along nicely. In all, the company produced $4.3 billion in operating cash flow in 2009, which was down from pre-crisis levels, but up from 2008. If cash production continues to move in the right direction, the company may soon find that it has the ability to start growing its dividend again -- perhaps significantly.

What the bulls say
Allstate is currently rated four out of a possible five stars on CAPS. While 520 members have given the stock a thumbs up, there have been enough naysayers to keep the stock from reaching CAPS' top rung.

One of the bulls is CAPS All-Star ontheemmis, a former Allstate employee who rated the stock an outperformer back in November of 2008, writing:

Current price is about 8-10 $below Book Price. I was employed by them for 38 years and know the corporate culture.They are a very conservative group and will not give away the store with lower premiums and they have a great handle on cost and claims frequency.

Since that pick, the stock has gained 27%, while book value has fallen slightly. But while the stock may not be as much of a bargain as it was when ontheemmis picked it, its current price-to-book multiple is still well below its historical range.

Get into the action
You can check out who else has been bullish on these stocks, as well as chime in with your own thoughts by heading over to CAPS. You may also want to check out a few of the other top-rated dividend payers above while you're there.

Dividend stocks could help you transform your portfolio from the flash-in-the-pan Florida Marlins into the dependable New York Yankees. And if you hate the Yankees, it's probably because they're so darn good, so darn often.

I like dividends and since you're reading this article, I'm going to guess that you like dividends. But Anand Chokkavelu thinks dividends are dumb.

The Steve Jobs Betrayal
You may already know that in the final year of his life, Jobs revealed a stunning betrayal — and told his biographer, "I will spend my last dying breath... and every penny of Apple's $40 billion in the bank to right this wrong." What was it that made Jobs so irate — and why could it make a few in-the-know investors some major profits over the coming months and years?

Enter your email address below to find out what made Jobs so enraged!

Pfizer is a Motley Fool Inside Value pick. Enterprise Products and Johnson & Johnson are Income Investor picks. Motley Fool Options has recommended a buy calls position on Johnson & Johnson. Try any of our Foolish newsletters today, free for 30 days.

Fool contributor Matt Koppenheffer owns shares of Johnson & Johnson, but does not own shares of any of the other companies mentioned. You can check out the stocks he's keeping an eye on by visiting his CAPS portfolio or connect with him on Twitter @KoppTheFool. The Fool's disclosure policy pays its dividends in reliability.


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Add your comment.

Compare Brokers

Fool Disclosure

DocumentId: 1129974, ~/Articles/ArticleHandler.aspx, 5/24/2012 10:25:18 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 1 hour ago Sponsored by:
DOW 12,529.75 33.60 0.27%
S&P 500 1,320.68 1.82 0.14%
NASD 2,839.38 -10.74 -0.38%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

5/24/2012 4:01 PM
ALL $33.43 Up +0.34 +1.03%
The Allstate Corp CAPS Rating: ***
MRO $24.88 Up +0.36 +1.47%
Marathon Oil Corp CAPS Rating: ****
PFE $22.14 Up +0.05 +0.23%
Pfizer, Inc. CAPS Rating: ****
VZ $41.39 Up +0.11 +0.27%
Verizon Communicat… CAPS Rating: ****
CAT $91.42 Down -1.05 -1.14%
Caterpillar, Inc. CAPS Rating: ****
EPD $49.51 Up +0.02 +0.04%
Enterprise Product… CAPS Rating: *****
JNJ $63.10 Up +0.44 +0.70%
Johnson & Johnson CAPS Rating: *****

Advertisement